Abstract
Most patients with minimal change nephrotic syndrome are steroid responsive and tolerate this medication. However, a substantial number of patients relapse frequently and become steroid dependent. These patients often require treatment with alternative immunosuppressive drugs to maintain remission and minimize steroid toxicity. Previous studies have suggested that mycophenolate mofetil is effective in treating these patients. However, there are limited data on the effectiveness of this agent in pediatric patients, specifically those with steroid-dependent nephrotic syndrome. The purpose of this study was to assess the efficacy and safety of mycophenolate mofetil therapy in children and adolescents with steroid-dependent nephrotic syndrome who failed other treatments. A retrospective chart review was performed on all patients with steroid-dependent nephrotic syndrome. Clinical characteristics, laboratory data and the relapse rate were assessed prior to and during mycophenolate mofetil treatment. Twenty-one patients, ages 2–17 years, with steroid-dependent nephrotic syndrome who were treated with mycophenolate mofetil between 2001–2005 were included in this review. The indication for mycophenolate mofetil use was steroid dependence in 17 and steroid toxicity in 4 patients. The mean duration of treatment was 1.0±0.5 years (range: 0.2–2.0 years). Patients treated with mycophenolate mofetil had a reduction in relapse rate from 0.80±0.41 to 0.47±0.43 relapses per month ( P <0.02). Side effects were mild and mostly gastrointestinal in nature. In 1 child, mycophenolate mofetil was discontinued due to varicella infection and not restarted. The findings indicate that mycophenolate mofetil is a useful adjunctive therapy in the treatment of patients with steroid-dependent nephrotic syndrome. It lowers the relapse rate by 40% and is well tolerated by patients with steroid-dependent nephrotic syndrome.
Similar content being viewed by others
References
International Study of Kidney Disease in Children (1978) Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int 13:159–165
Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr (1997) Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 8:769–776
Schwarz A (2001) New aspects of the treatment of nephrotic syndrome. J Am Soc Nephrol 12 [Suppl 17]:S44–47
Allison A, Eugui E (1993) Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil. Immunol Rev 125:5–28
Halloran P (1997) Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. Transplantation 63:39–47
Barletta GM, Smoyer WE, Bunchman TE, Flynn JT, Kershaw DB (2003) Use of mycophenolate mofetil in steroid dependent and resistant nephritic syndrome. Pediatr Nephrol 18:833–837
Bagga A, Hari P, Moudgil A, Jordan SC (2003) Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome. Am J Kidney Dis 42:1114–1120
Stadermann MB, Lilien MR, van de Kar NCAJ, Monnens LAH, Schroder CH (2003) Is biopsy required prior to cyclophosphamide in steroid-sensitive nephrotic syndrome? Clin Nephrol 690:315–317
Acknowledgements
This work was presented in part at the annual meeting of the Society of Pediatric Research, May 2004, San Francisco, CA, and published in abstract form ( Pediatr Res 2004; 55;570A).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Novak, I., Frank, R., Vento, S. et al. Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome. Pediatr Nephrol 20, 1265–1268 (2005). https://doi.org/10.1007/s00467-005-1957-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-005-1957-y